-- Preview Email Newsletter
| U.S. Congressional Tipoffs Involving Maine Newsletter for 2022-11-11 ( 3 items ) |
|
DeLauro, Pingree Announce GAO Report On Food Safety At Food And Drug Administration (10)
WASHINGTON, Nov. 11 -- Rep. Chellie Pingree, D-Maine, issued the following news release on Nov. 10, 2022:
U.S. Representatives Rosa DeLauro (CT-03) and Chellie Pingree (ME-01) today announced that the Government Accountability Office (GAO) released a report in response to their request that the GAO examine food contamination by chemical substances in our food.
"Let me be clear- these are forever chemicals that do not break down and may have a detrimental impact on the health of Americans," sai more PR
Senator Collins Urges DEA To Address 'Rainbow' Fentanyl & Illicit Pills That Target Teens & Young Adults (10)
WASHINGTON, Nov. 11 -- Sen. Susan M. Collins, R-Maine, issued the following news release and letter:
In response to the growing prevalence of "rainbow" fentanyl and illicit pills laced with deadly fentanyl, U.S. Senator Susan Collins wrote to the U.S. Drug Enforcement Agency (DEA) to request an update on the progress being made to stem the flow of fentanyl reaching communities.
"The flood of counterfeit, fentanyl-laced pills falsely marketed as legitimate prescriptions is driving a dramatic sp more PR
Senators Collins, King Applaud Sappi North America's Investment In Skowhegan Paper Mill (10)
WASHINGTON, Nov. 11 -- Sen. Susan M. Collins, R-Maine, issued the following news release:
U.S. Senators Susan Collins (R-Maine) and Angus King (I-Maine) applauded the announcement of a $418 million investment from Sappi North America, Inc. at the Somerset Mill in Skowhegan. The significant investment will help the mill convert Paper Machine No. 2 to diversify its specialty product line and double its production capacity. Construction of the expansion is expected to support 1,000 contractor jobs more PR
|
